Emerging Technologies
Array Behavioral Care adds three new executive members to its team, and a new senior vice president of regulatory affairs joins Elucid.
The company's computational solution uses AI, modeling and data analysis of naturally occurring proteins to generate superior antibodies, enzymes and vaccine immunogens.
Also, DeepTek and Alveofit obtained respective regulatory approvals in Thailand and the United States.
THE IQ-Creator Program supports healthcare professionals in creating content for underserved communities, while Aloud uses AI to dub videos in multiple languages.
The algorithm helps predict missed appointments, failure to schedule follow-up visits and late arrivals.
The company will use the funds to meet the growing demand for ElliQ, its conversational AI-powered robot that acts as a companion to seniors.
It explores for the first time the benefits of VR on the physical fitness of people with disabilities.
Investigations sponsored by the ISS National Laboratory will be performed, including tissue chip investigations to study liver regeneration and the immune aging process.
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.
The company announced its expansion into a Silicon Valley-based production facility to develop its collaborative robotic system.